Intravenous thrombolysis for acute ischaemic stroke in the setting of rivaroxaban use

Andrew J. Neal, Bruce C V Campbell, Arvind Chandratheva, Peter J. Hand, Stephen M. Davis

Research output: Contribution to journalArticleOtherpeer-review

7 Citations (Scopus)


The risk of thrombolysis in patients taking novel anticoagulants remains unclear. We describe a patient with a large acute ischaemic stroke, who had a low calibrated anti-factor Xa level, who safely received thrombolysis 15-17 hours after standard dose rivaroxaban without subsequent intracerebral haemorrhage.

Original languageEnglish
Pages (from-to)2013-2015
Number of pages3
JournalJournal of Clinical Neuroscience
Issue number11
Publication statusPublished - 1 Nov 2014
Externally publishedYes


  • Rivaroxaban
  • Stroke
  • Thrombolysis
  • Thrombolytic therapy

Cite this